000 | 01719 a2200517 4500 | ||
---|---|---|---|
005 | 20250517022142.0 | ||
264 | 0 | _c20150824 | |
008 | 201508s 0 0 eng d | ||
022 | _a1465-3621 | ||
024 | 7 |
_a10.1093/jjco/hyv037 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFukazawa, Satomi | |
245 | 0 | 0 |
_aLaminin β3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancer. _h[electronic resource] |
260 |
_bJapanese journal of clinical oncology _cJun 2015 |
||
300 |
_a533-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aCell Adhesion Molecules _xanalysis |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aColorectal Neoplasms _xchemistry |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aKalinin |
700 | 1 | _aShinto, Eiji | |
700 | 1 | _aTsuda, Hitoshi | |
700 | 1 | _aUeno, Hideki | |
700 | 1 | _aShikina, Atsushi | |
700 | 1 | _aKajiwara, Yoshiki | |
700 | 1 | _aYamamoto, Junji | |
700 | 1 | _aHase, Kazuo | |
773 | 0 |
_tJapanese journal of clinical oncology _gvol. 45 _gno. 6 _gp. 533-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jjco/hyv037 _zAvailable from publisher's website |
999 |
_c24706884 _d24706884 |